Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Clinical Characteristics-cognitive -
--->News
[+]The Project
[-]Locations
--->[+]Austria
--->[+]Belgium
--->[+]Czech Republic
--->[+]Denmark
--->[+]Finland
--->[-]France
--->Coordination
--->HD Associations
--->Amiens
--->Bordeaux
--->[-]Clermont-Ferrand
--->[-]Documents
--->Informed Consent
--->ERB Template
--->ERB
--->Lille
--->[+]Rouen
--->Strasbourg
--->[+]Germany
--->[+]Ireland
--->[+]Italy
--->[-]Netherlands
--->Coordination
--->HD Associations
--->Enschede
--->Groningen
--->Leiden
--->[-]Maastricht
--->[-]Documents
--->Informed Consent
--->ERB Templates
--->ERB
--->Nijmegen
--->[+]Norway
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[+]Spain
--->[+]Sweden
--->[+]Switzerland
--->[+]U.K.
--->[+]Outside Europe
[-]Working Groups
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[-]Young Adults
--->[+]Dates
--->[+]Meetings
--->Members
[-]Events
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Communication
--->Contact Form
--->Chat Rooms
--->Mailinglists - public
--->Newsletter
--->Job Offers
datedescriptionsizeauthor document 
03.08.26A comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in early stages of Huntington’s disease32 kBanonymousapplication/mswordj06-comparison--mmse-montreal-cognitiv... 
03.08.26Increased cognitive functioning in manifest HD - empirical evidence and computational modelling32 kBanonymousapplication/mswordj07-increased-cognitive-functioning 
03.08.26Cognitive Functions of the Putamen in Huntington’s Disease32 kBanonymousapplication/mswordj09-cognitive-functions-putamen 
03.08.26Development and characterization of the cognitive assessment battery (CAB-HD) for Huntington’s Disease clinical trials32 kBanonymousapplication/mswordj05-cab-hd 
03.08.26Measuring cognitive decline in Huntington’s Disease: a longitudinal analysis of the UHDRS cognitive battery32 kBanonymousapplication/mswordj04-cognitive-decline-in-hd 
03.08.26What are the best cognitive tests for clinical trials?: the devil is in the details32 kBanonymousapplication/mswordj02-best-cognitive-tests-clinical-trials 
03.08.26The potential of a composite cognitive score for tracking progression in Huntington's Disease32 kBanonymousapplication/mswordj03-cognitive-score-tracking-progression 
03.08.26Neuropathology of the ventral striatum and extended amygdala in Huntingon Disease32 kBanonymousapplication/mswordj10-neuropathology-ventral-striatum-ex... 
03.08.26Altered reward processing in pre-symptomatic carriers of the Huntington gene – hypercompensation as a potential mechanism32 kBanonymousapplication/mswordj11-hypercompensation-potential-mechan... 
03.08.26Multitasking processes are sensitive to early changes in pre-HD - evidence from longitudinal neurophysiological data32 kBanonymousapplication/mswordj16-multitasking-processes-are-sensitive 
03.08.26Apathy prevalence and clinical correlations in Huntington’s Disease32 kBanonymousapplication/mswordj17-apathy-prevalence-and-clinical-cor... 
03.08.26Dual task performance in Huntington’s Disease: comparing choice reaction time tasks32 kBanonymousapplication/mswordj15-comparing-choice-reaction-time-tasks 
03.08.26Cognitive and emotional contributions to quality of life in Huntington’s Disease32 kBanonymousapplication/mswordj14-cognitive-and-emotional-contributi... 
03.08.26Affective pictures perception in early Huntington's Disease: valence, arousal and brain responses32 kBanonymousapplication/mswordj12-valence--arousal-and-brain-responses 
03.08.26Distributed neural networks associated with emotion processing are altered in premanifest Huntington’s Disease and correlated with genetic load32 kBanonymousapplication/mswordj13-distributed-neural-networks 
03.08.26Cortisol levels are associated with verbal memory performance in the early stages of Huntington’s disease32 kBanonymousapplication/mswordj0x-cortisol-levels-verbal-memory 

Folder contains 16 documents.
about us | privacy statement | disclaimer | terms of use